№ lp_1_2_68005
File format: docx
Character count: 11480
File size: 131 KB
The document provides updated templates for patient registration and consent specifically for homecare medicines services, outlining sections for customization and consent processes.
Year:
2011
Region / City:
England
Topic:
Homecare Services, Patient Registration
Document Type:
Template
Organization / Institution:
Royal Pharmaceutical Society
Author:
NHMC
Target Audience:
Healthcare professionals, Homecare providers
Period of Validity:
Not specified
Approval Date:
17 October 2017
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2022
Region / City:
Arkansas
Theme:
Medicaid, Home and Community-Based Services
Document Type:
Program Guidelines
Agency:
Arkansas Medicaid
Author:
Division of Provider Services and Quality Assurance
Target Audience:
Healthcare providers and service organizations
Period of Action:
Ongoing, based on program criteria
Approval Date:
10-1-22
Date of Amendments:
10-1-22
Note:
Year
Year:
2013
Region / city:
UK
Topic:
Homecare Medicines
Document type:
Charter
Author:
NHS
Target audience:
Patients receiving homecare services, healthcare professionals
Period of validity:
N/A
Approval date:
N/A
Date of changes:
2013
Note:
Year
Target Audience:
IT and database administration teams
Supported SQL Server Version:
SQL Server 2017 Standard 64-bit
File Download Method:
WinSCP / SFTP
Log Backup Frequency:
Every 10 minutes
Replica Database Setup:
Quest LiteSpeed for SQL Server
Service Level:
Best effort
Support Contact:
HCHB Customer Services
Log Shipping Process:
Manual or automated
Security Features:
Encrypted transmission
System Requirements:
Modern dual-core processor, 16 GB RAM (for databases < 50 GB)
Automated Transaction Log Restore Process:
SQL Server job
Year:
2026
Region / City:
United Kingdom
Subject:
Homecare medication services
Document type:
Charter / Guidance
Organization:
NHS England
Author:
NHS England
Target audience:
Patients receiving homecare medicines
Period of applicability:
Ongoing from 2026
Approval date:
2026
Responsibilities outlined:
Patient, hospital team, GP, homecare provider
Consent requirement:
Yes
Information provided:
Homecare processes, delivery arrangements, patient rights
Job Title:
Pharmacy Technician Specialist, Homecare Medicines Management
Reports to:
Pharmacy Procurement Manager
Accountable to:
Pharmacy Procurement Manager
Grade:
Band 6
Unit/Department:
Pharmacy
Location:
Not specified
Qualifications:
BTEC in Pharmaceutical Science, NVQ Level 3 in Pharmacy Services or equivalent
Experience:
Minimum 3 years post-qualified experience, supervisory/management experience, hospital pharmacy experience
Skills:
Accuracy checking, training and assessing staff, SOP development, stock control systems, communication skills, problem solving, analytical skills, time management
Core Values:
Enthusiastic, reliable, motivated, confident, integrity, patient confidentiality, empathy, commitment to professional development
Core Behaviours:
Team working, flexibility, initiative, influence, motivation, analytical and prioritisation skills
Responsibilities:
Manage and develop homecare medicines management services, coordinate with healthcare teams, oversee service specifications, provide specialist advice, ensure compliance with SOPs, GMP, and COSHH, training and development of staff, quality and financial reporting, tender processes, risk management
Type:
Job description / professional role specification
Target Audience:
Pharmacy staff, healthcare administrators
Period of Service:
Ongoing
Year:
2026
Region / Country:
United Kingdom (England, Northern Ireland, Scotland, Wales)
Document Type:
Reporting Form
Organization:
NHS / Homecare Providers
Target Audience:
Patients, Carers, Healthcare Staff
Topics:
Patient complaints, Incident reporting, Medicines, Medical devices
Period of Use:
Current
Date Issued:
2026
Instructions Included:
Yes
Data Collected:
Personal details, Incident description, Medicines, Medical devices
Year:
2023
Region / City:
United States
Theme:
Statewide Longitudinal Data System (SLDS) Project Management
Document Type:
Template
Organization / Institution:
U.S. Department of Education
Author:
SLDS State Support Team
Target Audience:
State and local project managers, SLDS team members, vendors
Period of validity:
Ongoing
Approval Date:
January 2023
Date of Changes:
N/A
Year:
2022
Region / City:
Washington, DC
Theme:
Data management, Public health
Document type:
Notice
Organization / Institution:
Centers for Disease Control and Prevention (CDC)
Author:
Jeffrey M. Zirger
Target audience:
Grant and cooperative agreement applicants and awardees
Action period:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Year:
2026
Region / City:
United States
Theme:
Collaborative Care Program (CoCM) Documentation
Document Type:
Template
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Behavioral health care providers, healthcare professionals involved in CoCM
Validity Period:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2025
Region / City:
United States
Topic:
Family Planning Services
Document Type:
Policy Template
Organization / Institution:
Office of Population Affairs
Author:
Not specified
Target Audience:
Title X Program recipients, subrecipient agencies
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2018
Region / City:
British Columbia
Theme:
Medical Supplies Coverage for Gender Affirmation and Surgery
Document Type:
Guidelines
Organization:
Ministry of Social Development and Poverty Reduction
Author:
Unknown
Target Audience:
Medical practitioners (MDs, NPs)
Effective Date:
August 28, 2018
Approval Date:
August 28, 2018
Revision Date:
None
Note:
Study Summary 1.1 Please provide a brief summary of the study in the table below. A complete description of the study with detailed information should be provided in the body of the protocol. For sections not applicable to the study, mark them as N/A. Study Title Study Design Primary Objective/Purpose Secondary Objective(s)/Purposes Research Intervention(s) ClinicalTrials.gov NCT # Study Population Sample Size Study Duration for individual subjects Study Specific Abbreviations/ Definitions
Background 3.1 Provide the scientific or scholarly background for, rationale for, and significance of the research based on the existing literature and how will it add to existing knowledge. :
this section should be limited to only information directly related to the research questions and objectives. Do not include your full dissertation proposal. 3.2 Describe any relevant preliminary data (e.g. pilot data).
Procedures Involved 5.1 Describe and explain the study design. 5.2 Please select the methods that will be employed in this study (select all that apply):
☐ Audio/Video Recording ☐ Psychophysiological Recording ☐ Behavioral Interventions ☐ Record Review - Educational ☐ Behavioral Observations and Experimentations ☐ Record Review - Employee ☐ Deception ☐ Record Review- Medical ☐ Focus Groups ☐ Record Review - Other ☐ Interviews ☐ Specimen Collection or Analysis ☐ Investigational Medical Device – (e.g. Medical Mobile Applications) ☐ Surveys and/or Questionnaires ☐Psychometric Testing ☐ Other Social-Behavioral Procedures Provide a description of all research procedures being performed and when they are performed. (Upload any surveys, questionnaires, interview scripts, focus group scripts, debriefing scripts, psychometric tests, stimulus materials, intervention manuals, and data collection forms on the Local Site Documents page in the IRB application.) 5.3 Describe the procedures or interventions that are going to be conducted as part of the research project, but that would have been conducted anyway, even if the research was not occurring (i.e. standard of care procedures, activities that would occur in a classroom). 5.4 Describe the procedures performed to lessen the probability or magnitude of risks of items selected in 5.2.5. 5 If accessing or collecting existing data, describe: The data that will be collected during the study (e.g. demographics, medical history, etc.). Attach the data capture sheet(s) on the Local Site Documents page in the IRB application. How the data will be obtained, including how you have the authority to access the data. The source or location of the data (e.g. USF Epic, TGH Epic, Hillsborough County School records, CANVAS records, publicly available databases, etc.). 5.6 If collecting and/or analyzing biological specimens, describe: How the biological specimens will be or have been collected. How the biological specimens will be stored. How long the biological specimens will be stored. How the biological specimens will be used. The laboratories that will be used. Whether the collected biological specimens will undergo genetic testing. If so, indicate if this study is part of a Genome Wide Association Study (GWAS) and whether the data will be forwarded to the NIH dbGaP. 5.7 If there are plans for long-term follow-up (once all research related procedures are complete), what data will be collected during this period.
Data and Specimen Storage for Future Research 6.1 If data or specimens will be banked for future research studies, describe where the data or specimens will be stored, how long it/they will b:
the process to request a release, approvals required for release, who can obtain data or specimens, and the data to be provided with specimens.
) and join the S1NET. For guides with in depth examinations of performance measure definitions, go to:
https://www.milsuite.mil/book/docs/DOC-129783
Table of Contents (Hyperlinks to Sections):
Developing ‘Significant Duties and Responsibilities’ OER Narratives: Notes, Rules, and Instructions OER Narrative Prohibited Techniques, Inconsistencies, No-Go’s: Negative Comment Rules Referred OERs Narrative Comment Examples Block a. APFT and HT/WT Block b. Overall Performance Block c. Character (to include SHARP comments) Block d. Presence Block e. Intellect Block f. Leads Block g. Develops Block h. Achieves Senior Rater Potential Senior Rater Narrative Examples Senior Rater Narrative Comment Examples (for potential, promotion, school, etc.) Successive Assignments Other SR Comments (explanations of anything unusual about OER) Effective Words for Evaluations JUNIOR OFFICER PLATE (DA FORM 67-10-1) NOTE: 2LTs who have NOT completed BOLC, will not receive an OER until they complete BOLC (AC and ARNG; USAR officers can receive an OER before completing BOLC). The FROM date will be their commissioning date. All time until their BOLC graduation will be NONRATED on their first OER. OER PROFILING: OERs: Rater and Senior Rater Profiles are CONSTRAINED, meaning Officers are only allowed to grant 49% of each rank they rate with either an “EXCELS” (as Rater) or “MOST QUALIFIED” (as Senior Rater). HOWEVER, if you have an immature profile, and have only just begun rating/senior rating Officers of a certain rank, you are allowed a ONE TIME option of giving one of the first two evaluations you make at a particular grade, an “EXCELS” (as Rater) or “MOST QUALIFIED” (as Senior Rater). OER (OER SUPPORT FORM) PART III: Developing ‘Significant Duties and Responsibilities’ (blocks a., b., and c.): Refer to DA PAM 611-21 (https://www.milsuite.mil/book/groups/smartbookdapam611-21
) and DA PAM 600-3 (Commissioned Officer Professional Development and Career Management), to assist in the development of PART III, block d. As a minimum, the duty description will include pr:
- Number of personnel supervised, - Amount of resources under the rated officer’s control, - Scope of responsibilities. 3) Descriptions must be clear and concise with emphasis on specific functions required. 4) Note conditions unique to the assignment; e.g. RA officers assigned to FT support duties with RC units or USAR officers assigned to RA units OER NARRATIVES: Notes, Rules, and Instructions Rater and Senior Rater Narratives: - Requires candor and courage; frank and accurate assessment. - Quantify officer’s value relative to peers and do so in concert with rater/senior rater box check. - Are short; tell a simple story about the quality of officer being evaluated. - Are interesting and compelling. - Are looked at by selection board members when they are looking for in-depth information about a rated officer’s performance and potential. - Numbers; 1-10, write them out (e.g. one, two, ten). 11 or higher, write the number; e.g. 11, 15, 105. Exception, when a 1-10 is WITH an 11 or higher; e.g. “5 tool kits with 20 tools each.” - Fashion the narrative to the officer; double check use of “he/his” vs. “she/hers.” - Awards: Awards and/or special recognition received during the rating period may be cited in evaluation comments (for example, “received the Humanitarian Service Medal” or “named the Instructor of the Year”). - Raters and SR CAN use the officer’s name in the narrative; e.g. “1LT Joe was ….” Rater and Rater Narratives: - Focus on PERFORMANCE; explaining what the rated officer did and how well he/she did it. - Focus on specifics to quantify and qualify performance. - Raters should advocate the rated officer to the SR. - When there is no SR (due to lack of qualifications), rater’s narrative provides the input on both performance and potential. Senior Rater (SR) and SR Narrative (see SR Rater Narrative section for examples): - Focus on POTENTIAL, 3-5 years out (promotions, command, school, & assignments). - Can amplify box checks by using the narrative to clearly send the appropriate message to selection boards. - CANNOT mention Box Check. - Additional information for when SR is also Rater can be found in DA PAM 623-3, pg. 26, “DA Form 67–10–1, part VI: block c—Senior Rater Narrative.” OER Narrative Prohibited Techniques, Inconsistencies, No-Go’s: - School/Course Comments: Bullets about how a Soldier did in a school or course are ONLY allowed if that school did not produce an AER/DA Form 1059. - Narratives are not a laundry list of superlatives – more is not necessarily better. - Brief, unqualified superlatives or phrases, particularly if they may be considered trite. - Excessive use of technical acronyms, or phrases not commonly recognized. - Techniques aimed at making specific words, phrases, or sentences stand out from the rest of the narrative; e.g. excessive use of capital letters; unnecessary quotation marks; repeated use of exclamation points; wide spacing between selected words, phrases, or sentences to include double spacing within a paragraph or between paragraphs. - Inappropriate references to box checks; e.g “Would be TOP BLOCK if profile allowed” or “absolutely far exceeded the standard”. - Trying to quantify (e.g. “top 2% of my captains”) with a small population. - Stay in your lane/level; avoid comments like “Best 1LT in the Army” unless you’re the Army CoS. - Stating “the best ever”; having 10 in the population, 50 in the profile. - Using overused phrases and clichés that are counterproductive or overused; e.g. stellar, historic, “delivered a dazzling performance,” “hit the ground running,” consummate professional, and unlimited potential. - Using specific selection board-type language. Examples of this include, “definitely a 6+ Soldier”. - Don’t exaggerate; “If I could prove it, CPT X is an LTC disguised as a CPT.” - Be mindful of what IS NOT said; it can have the same impact as what is said; e.g. NOT having numbers, or quantifiable points. - Don’t say the sa
Note:
en
Topic:
Officer Evaluation, Narrative Guidelines
Document Type:
Guide
Target Audience:
Raters, Senior Raters
Date:
12 May 2025
Document Number:
EMA/152360/2016 rev.1
Modules:
2.5, 2.7.1, 2.7.2, 2.7.3, 2.7.4, 5.3.x.x
Type:
Regulatory submission template
Purpose:
Clinical overview, biopharmaceutical studies, clinical pharmacology, efficacy, safety, CSR body, CSR appendices
Applicant/MAH:
Not specified
Regulatory Agency:
European Medicines Agency
Confidentiality Guidance:
Annex 3 of POLICY/0070
Period:
2025
Year:
2020
Region / City:
United Kingdom
Topic:
Safeguarding, Child Protection, Sports Policy
Document Type:
Policy Template
Organization / Institution:
Bowls Club, National Governing Body
Author:
Not specified
Target Audience:
Coaches, Volunteers, Club Members, Parents, and Participants
Period of Validity:
2013–2021
Approval Date:
October 2013
Date of Last Review:
May 2020
Date of Next Review:
May 2021
Year:
2023
Region / city:
Australia
Subject:
Dangerous goods transport emergency response
Document type:
Template
Organization / institution:
Not specified
Author:
Not specified
Target audience:
Transportation companies, emergency responders, drivers
Effective period:
Not specified
Approval date:
Not specified
Modification date:
Not specified
Context:
A set of templates for preparing and implementing emergency response plans for the transport of dangerous goods.
Year:
Not specified
Region / City:
Not specified
Theme:
Risk management, regulatory capital, credit risk
Document type:
Disclosure template
Author:
Not specified
Target audience:
Regulatory bodies, financial institutions
Effective period:
Not specified
Approval date:
Not specified
Modification date:
Not specified
Year:
2026
Document Type:
Conference Paper Template
Organization:
CDIO Initiative
Intended Audience:
Academic Authors and Researchers
Scope:
Instructions for formatting, structuring, and submitting CDIO papers
Language:
English
Page Size:
A4
Margins:
Top 2.54 cm, Bottom 2.54 cm, Left 2.54 cm, Right 2.54 cm
Font:
Arial
Abstract Length Recommendation:
300 words for full papers, 50 words for short papers